Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ACACB | O00763 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.31 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31324249 | 0.77 | NR4A2 (0.42) | ESR1ACACBALDH1A1HTTNOS2 | |
| SCHEMBL8402539 | 0.74 | — | — | |
| SCHEMBL7486774 | 0.74 | ESR1 (0.44) | ESR1ALDH1A1PDPK1 | |
| SCHEMBL563577 | 0.74 | HCAR2 (0.47) | ACACBALDH1A1HTTPDPK1MEN1 | |
| SCHEMBL1914008 | 0.71 | PDPK1 (0.36) | ALDH1A1PDPK1 | |
| SCHEMBL2303273 | 0.71 | PDPK1 (0.51) | ESR1PDPK1MEN1KMT2A | |
| SCHEMBL6515252 | 0.71 | PDPK1 (0.51) | ESR1PDPK1MEN1KMT2A | |
| SCHEMBL2303277 | 0.71 | PDPK1 (0.51) | ESR1PDPK1MEN1KMT2A | |
| SCHEMBL29864 | 0.69 | — | — | |
| SCHEMBL930016 | 0.69 | ALDH1A1 (0.43) | ALDH1A1HTTNOS2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734985-A1 | PREVENTION, INHIBITION OR TREATMENT OF CONDITIONS OR DISORDERS MEDIATED BY UROCANATE REDUCTASE | IMPLEXION PHARMA AB (SE) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025003469-A1 | PREVENTION, INHIBITION OR TREATMENT OF CONDITIONS OR DISORDERS MEDIATED BY UROCANATE REDUCTASE | IMPLEXION PHARMA AB (SE) | 2025-01-02 | — | — | WO | disclosed |